# Overview of Novel Anticancer Drug Targets

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/overview-of-novel-anticancer-drug-targets/

## Facts

| Field | Value |
| --- | --- |
| Author Names | John K. Buolamwini,Haregewein Assefa |
| Citations | 3 |
| DOI | 10.1385/1-59259-380-1:03 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2411382971 |
| PMID | 12710193 |
| Type | book-chapter |
| Year | 2003 |

## Paper authors

- [Haregewein Assefa](https://scholariq.org/researchers/haregewein-assefa/)

## Paper journal

- [Humana Press eBooks](https://scholariq.org/journals/humana-press-ebooks/)

## Paper primary topic

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

## Paper topics

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.